| EP4364725 - SYSTEMS AND METHODS RELATING TO MEDICAL APPLICATIONS OF INVERSE THERMOSENSITIVE POLYMER FOAM FORMULATIONS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 06.02.2026 Database last updated on 21.03.2026 | |
| Former | The patent has been granted Status updated on 28.02.2025 | ||
| Former | Grant of patent is intended Status updated on 08.01.2025 | ||
| Former | Request for examination was made Status updated on 15.11.2024 | ||
| Former | The application has been published Status updated on 05.04.2024 | Most recent event Tooltip | 13.03.2026 | Lapse of the patent in a contracting state New state(s): RO | published on 15.04.2026 [2026/16] | Applicant(s) | For all designated states Critical Innovations, LLC 4228 Marine Ave Lawndale, CA 90260 / US | [2024/19] | Inventor(s) | 01 /
DONALDSON, Ross I. Lawndale, CA 90260 / US | 02 /
ARMSTRONG, Jonathan Lawndale, CA 90260 / US | 03 /
BUCHANAN, Oliver Lawndale, CA 90260 / US | 04 /
CAMBRIDGE, John Lawndale, CA 90260 / US | 05 /
FISHER, Timothy Lawndale, CA 90260 / US | 06 /
CRISTERNA, Nely Lawndale, CA 90260 / US | [2024/19] | Representative(s) | HGF HGF Limited 4th Floor, 1 City Square Leeds LS1 2ES / GB | [N/P] |
| Former [2024/19] | HGF HGF Limited 1 City Walk Leeds LS11 9DX / GB | Application number, filing date | 23207248.8 | 01.11.2023 | [2024/19] | Priority number, date | US202263423308P | 07.11.2022 Original published format: US 202263423308 P | [2024/19] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP4364725 | Date: | 08.05.2024 | Language: | EN | [2024/19] | Type: | B1 Patent specification | No.: | EP4364725 | Date: | 02.04.2025 | Language: | EN | [2025/14] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 08.01.2024 | Classification | IPC: | A61K9/12, A61L15/00, A61L15/26, A61L15/42, B65D83/00, A61K47/10 | [2024/19] | CPC: |
A61K9/0014 (EP);
C08J9/146 (US);
A61K47/10 (EP);
A61K9/12 (EP);
A61K9/124 (EP);
A61L26/0019 (EP,US);
A61L26/0076 (US);
A61L26/0085 (EP,US);
B65D83/285 (EP);
B65D83/382 (EP);
B65D83/42 (EP);
B65D83/46 (EP);
| C-Set: |
A61L26/0019, C08L71/02 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/51] |
| Former [2024/19] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | SYSTEME UND VERFAHREN IM ZUSAMMENHANG MIT MEDIZINISCHEN ANWENDUNGEN VON INVERSEN WÄRMEEMPFINDLICHEN POLYMERSCHAUMSTOFFFORMULIERUNGEN | [2024/19] | English: | SYSTEMS AND METHODS RELATING TO MEDICAL APPLICATIONS OF INVERSE THERMOSENSITIVE POLYMER FOAM FORMULATIONS | [2024/19] | French: | SYSTÈMES ET PROCÉDÉS RELATIFS À DES APPLICATIONS MÉDICALES DE FORMULATIONS DE MOUSSE POLYMÈRE THERMOSENSIBLE INVERSE | [2024/19] | Examination procedure | 08.11.2024 | Amendment by applicant (claims and/or description) | 08.11.2024 | Examination requested [2024/51] | 08.11.2024 | Date on which the examining division has become responsible | 09.01.2025 | Communication of intention to grant the patent | 20.02.2025 | Fee for grant paid | 20.02.2025 | Fee for publishing/printing paid | 20.02.2025 | Receipt of the translation of the claim(s) | Divisional application(s) | EP25166315.9 / EP4570240 | Opposition(s) | 05.01.2026 | No opposition filed within time limit [2026/11] |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 02.04.2025 | BG | 02.04.2025 | CZ | 02.04.2025 | DK | 02.04.2025 | EE | 02.04.2025 | ES | 02.04.2025 | FI | 02.04.2025 | HR | 02.04.2025 | IT | 02.04.2025 | LV | 02.04.2025 | NL | 02.04.2025 | PL | 02.04.2025 | RO | 02.04.2025 | SK | 02.04.2025 | SM | 02.04.2025 | NO | 02.07.2025 | RS | 02.07.2025 | GR | 03.07.2025 | IS | 02.08.2025 | PT | 04.08.2025 | [2026/16] |
| Former [2026/11] | AT | 02.04.2025 | |
| BG | 02.04.2025 | ||
| CZ | 02.04.2025 | ||
| DK | 02.04.2025 | ||
| EE | 02.04.2025 | ||
| ES | 02.04.2025 | ||
| FI | 02.04.2025 | ||
| HR | 02.04.2025 | ||
| IT | 02.04.2025 | ||
| LV | 02.04.2025 | ||
| NL | 02.04.2025 | ||
| PL | 02.04.2025 | ||
| SK | 02.04.2025 | ||
| SM | 02.04.2025 | ||
| NO | 02.07.2025 | ||
| RS | 02.07.2025 | ||
| GR | 03.07.2025 | ||
| IS | 02.08.2025 | ||
| PT | 04.08.2025 | ||
| Former [2025/49] | AT | 02.04.2025 | |
| BG | 02.04.2025 | ||
| ES | 02.04.2025 | ||
| FI | 02.04.2025 | ||
| HR | 02.04.2025 | ||
| LV | 02.04.2025 | ||
| NL | 02.04.2025 | ||
| PL | 02.04.2025 | ||
| NO | 02.07.2025 | ||
| RS | 02.07.2025 | ||
| GR | 03.07.2025 | ||
| IS | 02.08.2025 | ||
| PT | 04.08.2025 | ||
| Former [2025/48] | AT | 02.04.2025 | |
| BG | 02.04.2025 | ||
| ES | 02.04.2025 | ||
| FI | 02.04.2025 | ||
| HR | 02.04.2025 | ||
| NL | 02.04.2025 | ||
| PL | 02.04.2025 | ||
| NO | 02.07.2025 | ||
| RS | 02.07.2025 | ||
| GR | 03.07.2025 | ||
| PT | 04.08.2025 | ||
| Former [2025/46] | ES | 02.04.2025 | |
| FI | 02.04.2025 | ||
| NL | 02.04.2025 | ||
| PT | 04.08.2025 | ||
| Former [2025/43] | NL | 02.04.2025 | Documents cited: | Search | [X] US2012087872 (TAMARKIN DOV et al.) | [X] EP3539571 (CRITICAL INNOVATIONS LLC et al.) | [X] WO2009090558 (FOAMIX LTD et al.) | [X] GB1561423 (MUNDIPHARMA AG et al.) | by applicant | US11207060 | US4474752 | US6316011 | US2011294760 | US2005008610 | US2005147585 | US2011087207 | US2008181952 | US2007191768 | US8062282 | US2008208163 | US2008031847 | US2013158589 | US8871248 | US9283278 | US9603966 | US9884136 | US2017216480 | US2018169012 | US202217876187 | US9616203 | US10046147 | US10814119 | US2021106344 |